(5) reported that a novel human monoclonal antibody (32A9), as a GPC-3-specifc antibody which efficiently eliminated GPC3-positive HCC cells in vitro and induced HCC xenograft tumor regressions in vivo. The gene discussed is GPC3; the disease is hepatocellular carcinoma.